estriol has been researched along with Cognitive Decline in 1 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacKenzie-Graham, A | 1 |
| Brook, J | 1 |
| Kurth, F | 1 |
| Itoh, Y | 1 |
| Meyer, C | 1 |
| Montag, MJ | 1 |
| Wang, HJ | 1 |
| Elashoff, R | 1 |
| Voskuhl, RR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-Blind, Placebo Controlled Trial of Estriol Treatment in Women With Multiple Sclerosis: Effect on Cognition.[NCT01466114] | Phase 2 | 64 participants (Anticipated) | Interventional | 2011-10-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for estriol and Cognitive Decline
| Article | Year |
|---|---|
Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry.
Topics: Adult; Atrophy; Cognitive Dysfunction; Estriol; Female; Gray Matter; Humans; Magnetic Resonance Imag | 2018 |